methylprednisolone and mitoxantrone

methylprednisolone has been researched along with mitoxantrone in 68 studies

Research

Studies (68)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	19 (27.94)	18.2507
2000's	38 (55.88)	29.6817
2010's	11 (16.18)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, X; Lin, X; Skolnik, S; Wang, J	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Cabanillas, F	2
Bernstein, EF; Spielvogel, RL; Topolsky, DL	1
Erturk, G; Gümrük, F; Gurgey, A; Hicsönmez, G; Karadeniz, N; Ozsoylu, S; Tuncer, AM; Zamani, VP	1
Cabanillas, F; Hagemeister, FB; Lee, MS; McLaughlin, P; Pate, O; Rodriguez, MA; Romaguera, J; Sarris, A; Swan, F; Younes, A	1
Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A	1
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W	1
Bosly, A; Coiffier, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Reyes, F; Sebban, C; Tilly, H	1
Cabanillas, F; Hagemeister, FB; Hill, D; McLaughlin, P; Moore, DF; Rodriguez, MA; Romaguera, JE; Sarris, AH; Swan, F; Younes, A	1
Cetin, M; Güler, E; Hiçsönmez, G; Mufti, GJ; Ozbek, N; Sayli, T; Tuncer, AM	1
Bodenstein, H; Dietzfelbinger, H; Eimermacher, H; Engert, A; Freund, M; Herrmann, R; Hiddemann, W; Kreuser, ED; Landys, K; Nahler, M; Neubauer, A; Parwaresch, R; Reuss-Borst, M; Stauder, R; Stein, H; Tiemann, M; Tirier, C; Trümper, L; Unterhalt, M	1
Atkins, HL; Curtis, JE; Lipton, JH; Messner, HA; Minden, MD	1
Chandra, J; Keating, M; McConkey, DJ; McDonnell, TJ; Plunkett, W; Reed, JC; Wright, S	1
Rodriguez, MA	1
Berry, I; Brochet, B; Cabanis, E; Clanet, M; Confavreux, C; Edan, G; Froment, JC; Gandon, JM; Iba-Zizen, MT; Lai, HM; Lubetzki, C; Lyon-Caen, O; Miller, D; Moseley, I; Rolland, Y; Sabouraud, O	1
Cabanillas, F; Rodriguez-Monge, EJ	1
Bachier, C; Cabanillas, F; Hagemeister, FB; McLaughlin, P; Preti, H; Rodriguez, MA; Romaguera, JE; Sarris, AH; Weber, D; Younes, A	1
Berger, E; Rumbach, L	1
Rieckmann, P; Toyka, KV	1
Ahmed, T; Baskind, P; Darzynkiewicz, Z; Feldman, EJ; Goff, H; Pozzuoli, M; Santos, S; Seiter, K; Traganos, F	1
Chiusolo, P; Di Febo, AL; La Barbera, EO; Laurenti, L; Leone, G; Marra, R; Menichella, G; Piccirillo, N; Sica, S; Sorà, E; Teofili, L	1
Balaguer-Martínez, JV; Castillo-Pallarés, FJ; Ferrer Albiach, C; Pallardó-Calatayud, J; Romero-de-Avila, C; Ruiz Hernández, G	1
Hosomi, Y; Shibuya, M	1
Beguin, C; Carton, H; D'Hooghe, MB; Dooms, G; Lissoir, F; Sindic, CJ; van de Wyngaert, FA	1
Hara, T; Hattori, H; Ishii, S; Matsuzaki, A; Suminoe, A	1
Lublin, FD	1
de Magalhaes-Silverman, M; Gingrich, RD; Hayashi, M; Hohl, RJ; Lee, CK; Schlueter, A; Strauss, RG	1
Ayyildiz, O; Bolaman, Z; Demir, S; Kadiköylü, G; Köseoğlu, M; Müftüoğlu, E; Sönmez, HM	1
Ayala, A; Cabanillas, F; Hagemeister, FB; Hess, M; Lee, MS; McLaughlin, P; Preti, A; Rodriguez, MA; Romaguera, J; Sarris, A; Smith, TL; Tsimberidou, AM; Yang, Y; Younes, A	1
Pender, MP; Wolfe, NP	1
O'Connor, P	1
Castellà, MD; Montalban, X; Pericot, I; Río, J; Rovira, A; Tintoré, M	1
Cetin, M; Erdemli, E; Gürgey, A; Hiçsönmez, G; Okur, H	1
Hohlfeld, R; Jarius, S; Voltz, R	1
Aslan, D; Cetin, M; Hiçsönmez, G; Ozyürek, E; Tuncer, AM; Unal, S; Yenicesu, I	1
Edan, G	1
Brandt, T; Gross, A; Hohlfeld, R; Jahn, K; Strupp, M; Zingler, VC	1
Brandt, T; Gross, A; Hohlfeld, R; Jahn, K; Nabauer, M; Strupp, M; Zingler, VC	1
Cabanillas, F; Cox, JD; Ha, CS; Lee, MS; McLaughlin, P; Mesina, OM; Rodriguez, MA; Romaguera, JE; Tucker, SL; Younes, A	1
Bartolozzi, F; Chiusolo, P; Laurenti, L; Leone, G; Marra, R; Piccirillo, N; Sica, S; Sorá, F	1
Fox, EJ	1
Alix, T; Bénateau, H; Boutard, P; Jeanne-Pasquier, C; Minckes, O; Nicolas, J; Rysanek, B	1
Bakshi, A; Gujral, S; Gupta, S; Nair, R; Parikh, P; Prabhash, K; Sengar, M	1
Aracil, M; Banerjee, D; Bertino, JR; Elisseyeff, Y; Humeniuk, R; Jimeno, J; Lewis, LD; Longo-Sorbello, GS; Menon, LG; Mishra, PJ; Saydam, G	1
Chaperon, J; Coustans, M; Edan, G; Le Page, E; Leray, E; Morrissey, SP; Taurin, G	1
Bielecki, B; Glabinski, A; Mazurek, A; Wolinski, P	1
Glabinski, A; Jalosinski, M; Karolczak, K; Mazurek, A	1
Bouillaguet, S; Cabaret, M; de Sèze, J; Dubois, G; Dujardin, K; Ferriby, D; Stojkovic, T; Vermersch, P; Zéphir, H	1
Agaoglu, J; Icen, M; Kale, N; Tanik, O; Yazici, I	1
Bergamaschi, G; Corazza, GR; Girino, M; Gobbi, PG; Lambelet, P; Perfetti, V; Valentino, F	1
Edan, G; Le Page, E	1
Abellán, I; Belenguer, A; Boscá, I; Casanova, B; Coret, F; Fernández, P; Magraner, MJ; Mallada, J; Montalbán, X; Pascual, AM; Sanz, MA; Sempere, AP; Téllez, N	1
Saida, T	1
Dresler, M; Genzel, L; Kluge, M; Rosenhagen, M; Schüssler, P; Steiger, A; Weber, F	1
Myhr, KM	1
Flaig, M; Gerdes, LA; Hohlfeld, R; Kümpfel, T; Wollenberg, A	1
Comi, G; Edan, G; Filippi, M; Le Page, E; Leray, E; Rocca, MA	1
Bozzoli, V; D'Aló, F; Giachelia, M; Hohaus, S; Larocca, LM; Leone, G; Martini, M; Massini, G; Tisi, MC; Voso, MT	1
Havla, J; Hohlfeld, R; Kümpfel, T	1
Cabre, P; Jeannin, S; Marignier, R; Merle, H; Olindo, S; Smadja, D	1
Cocuzza, S; Di Mauro, P; Falsaperla, R; Ledda, C; Lubrano, R; Matin, N; Pavone, P; Serra, A; Tabatabaie, O; Vitaliti, G	1

Reviews

16 review(s) available for methylprednisolone and mitoxantrone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Factors that influence prognosis of intermediate-grade lymphomas at relapse. Cancer treatment and research, 1996, Volume: 85 Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Outcome Assessment, Health Care; Prognosis	1996
[New therapeutic strategies in multiple sclerosis]. La Revue de medecine interne, 1999, Volume: 20 Suppl 3 Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents; Brain; Clinical Trials as Topic; Disease Progression; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Neuroprotective Agents; Peptides; Polymers; Recurrence	1999
Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG]. European neurology, 1999, Volume: 42, Issue:3 Topics: Adjuvants, Immunologic; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Peptides; Pulse Therapy, Drug	1999
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2001, Volume: 28, Issue:10 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Ifosfamide; Lung Neoplasms; Lymphoma; Mesna; Methylprednisolone; Mitoxantrone	2001
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis. Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9 Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Fetal Blood; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Mercaptopurine; Methotrexate; Methylprednisolone; Mitoxantrone; Prednisolone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vincristine	2001
Therapeutic approaches to secondary progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2002, Volume: 8, Issue:1 Topics: Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Cladribine; Clinical Trials as Topic; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive	2002
Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects. Internal medicine journal, 2002, Volume: 32, Issue:11 Topics: Adjuvants, Immunologic; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Disease Progression; Genetic Predisposition to Disease; Glatiramer Acetate; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Interferon-beta; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Mitoxantrone; Models, Theoretical; Multiple Sclerosis; Peptides	2002
Key issues in the diagnosis and treatment of multiple sclerosis. An overview. Neurology, 2002, Sep-24, Volume: 59, Issue:6 Suppl 3 Topics: Clinical Trials as Topic; Disease Progression; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Peptides	2002
[Diagnosis and treatment of multiple sclerosis. Update, 2003]. MMW Fortschritte der Medizin, 2003, May-26, Volume: 145 Suppl 2 Topics: Acute Disease; Adjuvants, Immunologic; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Controlled Clinical Trials as Topic; Cross-Over Studies; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Longitudinal Studies; Methylprednisolone; Mitoxantrone; Multicenter Studies as Topic; Multiple Sclerosis; Natalizumab; Peptides; Pilot Projects; Prospective Studies; Recurrence; Time Factors	2003
[Aggressive multiple sclerosis. Definition and specific therapeutic indication]. Presse medicale (Paris, France : 1983), 2004, Feb-14, Volume: 33, Issue:3 Topics: Adjuvants, Immunologic; Adult; Analgesics; Anti-Inflammatory Agents; Clinical Trials as Topic; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Monitoring, Physiologic; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuroprotective Agents; Patient Selection; Placebos; Risk Assessment; Risk Factors; Time Factors	2004
Management of worsening multiple sclerosis with mitoxantrone: a review. Clinical therapeutics, 2006, Volume: 28, Issue:4 Topics: Anti-Inflammatory Agents; Clinical Trials, Phase II as Topic; Disease Progression; Humans; Immunosuppressive Agents; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Patient Selection; Randomized Controlled Trials as Topic	2006
Long-term experience with induction treatment regimens in multiple sclerosis. Journal of the neurological sciences, 2009, Feb-01, Volume: 277 Suppl 1 Topics: Adult; Central Nervous System; Clinical Protocols; Drug Therapy, Combination; Early Diagnosis; Female; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Treatment Outcome	2009
[Treatment of NMO]. Rinsho shinkeigaku = Clinical neurology, 2009, Volume: 49, Issue:11 Topics: Acute-Phase Reaction; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Humans; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Methylprednisolone; Mitoxantrone; Neuromyelitis Optica; Plasma Exchange; Prednisolone; Pulse Therapy, Drug; Recurrence; Rituximab	2009
[2012: Update on diagnosis and treatment of multiple sclerosis]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:17 Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Brain; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Fingolimod Hydrochloride; Glatiramer Acetate; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasmapheresis; Propylene Glycols; Pulse Therapy, Drug; Sphingosine; Spinal Cord	2012
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data. Human vaccines & immunotherapeutics, 2015, Volume: 11, Issue:12 Topics: Autoimmune Diseases; Child; Chorea; Cyclophosphamide; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Immunotherapy; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Natalizumab; Nervous System; Neurodegenerative Diseases; Neuromyelitis Optica; Obsessive-Compulsive Disorder; Plasma Exchange; Rituximab; Streptococcal Infections; Tourette Syndrome	2015

Trials

23 trial(s) available for methylprednisolone and mitoxantrone

Article	Year
High remission rate in acute myeloblastic leukemia in children treated with high-dose methylprednisolone. European journal of haematology, 1992, Volume: 48, Issue:4 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Liver; Male; Methylprednisolone; Mitoxantrone; Remission Induction; Spleen; Thioguanine; Vincristine	1992
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2 Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neoplasm Staging; Oncogenes; Polymerase Chain Reaction; Prednisone; Procarbazine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Remission Induction; Treatment Outcome; Vincristine	1994
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy. Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine	1994
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte). Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:8 Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Vindesine	1993
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas. Investigational new drugs, 1994, Volume: 12, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cross-Over Studies; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy	1994
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group. Leukemia, 1996, Volume: 10, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednimustine; Remission Induction; Treatment Outcome; Vincristine	1996
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:2 Topics: Adjuvants, Immunologic; Adult; Alopecia; Amenorrhea; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukopenia; Magnetic Resonance Imaging; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis	1997
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma. Leukemia & lymphoma, 1998, Volume: 32, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Paclitaxel; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Treatment Outcome	1998
Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia. Leukemia & lymphoma, 2000, Volume: 38, Issue:3-4 Topics: Actuarial Analysis; Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Conjunctivitis; Cytarabine; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Humans; Hyperbilirubinemia; Leukemia, Myeloid; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Remission Induction; Risk; Stomatitis; Stroke Volume; Survival Analysis; Survival Rate; Treatment Outcome; Tretinoin; Ventricular Dysfunction, Left	2000
MiCMA: an alternative treatment for refractory or recurrent Hodgkin's disease. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:7 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Treatment Outcome	2000
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis. Acta neurologica Belgica, 2001, Volume: 101, Issue:4 Topics: Adult; Alopecia; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylene Blue; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Nausea; Patient Dropouts; Phlebitis; Pulmonary Embolism; Pyrrolidines; Recurrence; Severity of Illness Index; Treatment Outcome; Vomiting	2001
A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation. Bone marrow transplantation, 2002, Volume: 29, Issue:8 Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Cytarabine; Drug Resistance, Neoplasm; Drug Tolerance; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neutropenia; Salvage Therapy	2002
Treatment of blastic phase chronic myeloid leukemia with mitoxantrone, cytosine arabinoside and high dose methylprednisolone. Haematologia, 2002, Volume: 32, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cytarabine; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Remission Induction; Survival Analysis; Treatment Outcome	2002
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma. Blood, 2002, Dec-15, Volume: 100, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vidarabine; Vincristine	2002
[The effect of combined mitoxantrone and methylprednisolone therapy in primary and secondary progressive multiple sclerosis. An applied study in 65 patients]. Der Nervenarzt, 2005, Volume: 76, Issue:6 Topics: Adult; Aged; Analgesics; Disease Progression; Drug Combinations; Female; Humans; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Prognosis; Recovery of Function; Secondary Prevention; Treatment Outcome	2005
Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis. European neurology, 2005, Volume: 54, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Echocardiography; Female; Heart; Heart Diseases; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis	2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. International journal of radiation oncology, biology, physics, 2005, Sep-01, Volume: 63, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, bcl-2; Humans; Lymphoma, Follicular; Methylprednisolone; Middle Aged; Mitoxantrone; Polymerase Chain Reaction; Prednisone; Procarbazine; Prospective Studies; Translocation, Genetic; Vincristine	2005
Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation: a salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma. Cancer, 2006, Feb-15, Volume: 106, Issue:4 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Recurrence; Salvage Therapy; Transplantation, Autologous	2006
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients. Journal of neurology, neurosurgery, and psychiatry, 2008, Volume: 79, Issue:1 Topics: Adult; Antineoplastic Agents; Antiviral Agents; Azathioprine; Brain; Demography; Disability Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Observation; Peptides; Prevalence; Recurrence	2008
[Cognitive impact of mitoxantrone and methylprednisolone in multiple sclerosis: an open label study]. Revue neurologique, 2008, Volume: 164, Issue:1 Topics: Adult; Analgesics; Anti-Inflammatory Agents; Cognition Disorders; Depression; Disease Progression; Female; Humans; Male; Memory; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Neuropsychological Tests; Psychomotor Performance	2008
Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs. Bone marrow transplantation, 2009, Volume: 44, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Disease-Free Survival; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Recurrence; Salvage Therapy; Survival Rate; Time Factors	2009
Off-line memory consolidation impairments in multiple sclerosis patients receiving high-dose corticosteroid treatment mirror consolidation impairments in depression. Psychoneuroendocrinology, 2010, Volume: 35, Issue:8 Topics: Adrenal Cortex Hormones; Adult; Aged; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Memory; Memory Disorders; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Neuroprotective Agents; Psychomotor Performance; Sleep; Sleep Wake Disorders	2010
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial. Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:12 Topics: Adult; Brain; Drug Administration Schedule; Drug Therapy, Combination; Female; Gadolinium; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Neuroimaging; Severity of Illness Index	2011

Other Studies

29 other study(ies) available for methylprednisolone and mitoxantrone

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:2 Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity	2011
Non-Hodgkin's lymphomas: a review of the M.D. Anderson experience. Seminars in oncology, 1992, Volume: 19, Issue:1 Suppl 1 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Salvage Therapy; Texas; Vincristine	1992
Recurrent neutrophilic eccrine hidradenitis. The British journal of dermatology, 1992, Volume: 127, Issue:5 Topics: Adult; Cytarabine; Eccrine Glands; Female; Hidradenitis; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Methylprednisolone; Mitoxantrone; Recurrence; Skin	1992
Experience with salvage regimens at M.D. Anderson Hospital. Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoguazone; Mitoxantrone; Remission Induction; Survival Rate	1991
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prospective Studies; Recurrence; Salvage Therapy; Vincristine	1995
High-dose methylprednisolone, low-dose cytosine arabinoside, and mitoxantrone in children with myelodysplastic syndromes. Hematologic pathology, 1995, Volume: 9, Issue:3-4 Topics: Adolescent; Child; Child, Preschool; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Mitoxantrone; Myelodysplastic Syndromes	1995
Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post-remission bone marrow transplant--a pilot study. European journal of haematology, 1996, Volume: 57, Issue:1 Topics: Adolescent; Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Transplantation; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Pilot Projects; Remission Induction; Survival Rate; Vincristine	1996
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. Journal of immunology (Baltimore, Md. : 1950), 1996, Apr-01, Volume: 156, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-2-Associated X Protein; DNA, Neoplasm; Endonucleases; Glucocorticoids; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Methylprednisolone; Mitoxantrone; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Vidarabine	1996
Long-term follow-up of platinum-based lymphoma salvage regimens. The M.D. Anderson Cancer Center experience. Hematology/oncology clinics of North America, 1997, Volume: 11, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Dexamethasone; Disease-Free Survival; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Mesna; Methylprednisolone; Methylprednisolone Hemisuccinate; Mitoxantrone; Prognosis; Salvage Therapy; Texas; Treatment Outcome	1997
[Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?]. Revista espanola de medicina nuclear, 2001, Volume: 20, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Fatal Outcome; Follow-Up Studies; Gallium Radioisotopes; Gastrectomy; Gastroscopy; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Mesna; Methylprednisolone; Mitoxantrone; Neoplasm Recurrence, Local; Paclitaxel; Prednisone; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Stomach Neoplasms; Stomach Ulcer; Tomography, X-Ray Computed; Vincristine	2001
Serial gadolinium-enhanced MRI in acute attack of multiple sclerosis treated with plasma exchange. Journal of neurology, 2003, Volume: 250, Issue:2 Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Plasma Exchange	2003
The potential effect of short-course high-dose steroid on the maturation and apoptosis of leukemic cells in a child with acute megakaryoblastic leukemia. Leukemia & lymphoma, 2003, Volume: 44, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Marrow Cells; Child, Preschool; Cytarabine; Flow Cytometry; Humans; Leukemia, Megakaryoblastic, Acute; Male; Methylprednisolone; Mitoxantrone; Time Factors; Treatment Outcome	2003
Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment. Leukemia research, 2004, Volume: 28, Issue:1 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow Cells; CD13 Antigens; Child; Child, Preschool; Cytarabine; Female; Humans; Leukemia, Myeloid; Leukemic Infiltration; Lipopolysaccharide Receptors; Male; Methylprednisolone; Mitoxantrone; Prognosis; Remission Induction; Survival Rate; Thioguanine; Treatment Outcome	2004
[Mandibular chloroma]. Revue de stomatologie et de chirurgie maxillo-faciale, 2007, Volume: 108, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Diagnosis, Differential; Female; Humans; Infant; Mandibular Neoplasms; Methotrexate; Methylprednisolone; Mitoxantrone; Sarcoma, Myeloid	2007
The effect of short-term intensive chemotherapy on reactivation of tuberculosis. Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mesna; Methylprednisolone; Middle Aged; Mitoxantrone; Mycobacterium tuberculosis; Prednisone; Retrospective Studies; Tuberculosis; Vincristine; Virus Activation	2007
Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity. Leukemia, 2007, Volume: 21, Issue:12 Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Line, Tumor; Cytarabine; Depsipeptides; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, Large B-Cell, Diffuse; Methylprednisolone; Mice; Mice, SCID; Mitochondria; Mitoxantrone; Oxidative Stress; Peptides, Cyclic; Specific Pathogen-Free Organisms; Xenograft Model Antitumor Assays	2007
Treatment of multiple sclerosis with methylprednisolone and mitoxantrone modulates the expression of CXC chemokine receptors in PBMC. Journal of clinical immunology, 2008, Volume: 28, Issue:2 Topics: Adult; Dose-Response Relationship, Drug; Female; Gene Expression; Humans; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Receptors, CXCR; Receptors, CXCR3; Receptors, CXCR4; Receptors, CXCR5; Receptors, Interleukin-8A; Receptors, Interleukin-8B	2008
The effects of methylprednisolone and mitoxantrone on CCL5-induced migration of lymphocytes in multiple sclerosis. Acta neurologica Scandinavica, 2008, Volume: 118, Issue:2 Topics: Analgesics; Central Nervous System; Chemokine CCL5; Chemotaxis, Leukocyte; Glucocorticoids; Humans; In Vitro Techniques; Lymphocytes; Methylprednisolone; Mitoxantrone; Multiple Sclerosis	2008
Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2008, Volume: 29, Issue:6 Topics: Activities of Daily Living; Autoimmune Diseases; Autoimmunity; Brain; Cluster Analysis; Connective Tissue Diseases; Disease Progression; Familial Mediterranean Fever; Gait Disorders, Neurologic; Humans; Interferon-beta; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Paraparesis; Spondylitis, Ankylosing; Treatment Failure	2008
Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required. Multiple sclerosis (Houndmills, Basingstoke, England), 2009, Volume: 15, Issue:11 Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents; Child; Cohort Studies; Female; Humans; Interferon Type I; Leukemia, Myeloid, Acute; Male; Mediterranean Region; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Prospective Studies; Recombinant Proteins; Risk Assessment; Young Adult	2009
[Pharmacological treatment of multiple sclerosis]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2010, Mar-11, Volume: 130, Issue:5 Topics: Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Glatiramer Acetate; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Natalizumab; Peptides; Secondary Prevention	2010
Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 2011, Volume: 17, Issue:4 Topics: Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Multiple Sclerosis; Sweet Syndrome; Treatment Outcome	2011
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. Leukemia & lymphoma, 2012, Volume: 53, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Genotype; Humans; Interleukin-10; Interleukin-6; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neoplasm Proteins; NF-kappa B p50 Subunit; Phenotype; Polymorphism, Single Nucleotide; Prednisone; Prognosis; Promoter Regions, Genetic; Rituximab; Sequence Deletion; Treatment Outcome; Vincristine; Young Adult	2012
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study. Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Cohort Studies; Disability Evaluation; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neuromyelitis Optica; Prospective Studies; Radiography; Recurrence; Spinal Cord; Treatment Outcome	2013